SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001104659-20-120571
Filing Date
2020-11-02
Accepted
2020-11-02 17:00:05
Documents
15
Effectiveness Date
2020-11-02

Document Format Files

Seq Description Document Type Size
1 DEFM14A tm2023267-15_defm14a.htm DEFM14A 7521657
2 GRAPHIC lg_neurotrope-4c.jpg GRAPHIC 187232
3 GRAPHIC lg_metuchen-4clr.jpg GRAPHIC 397025
4 GRAPHIC sg_joshuan-silverman.jpg GRAPHIC 12602
5 GRAPHIC tm2023267d3-fc_organ4c.jpg GRAPHIC 63345
6 GRAPHIC tm2023267d3-fc_org2.jpg GRAPHIC 1434337
7 GRAPHIC tm2022154d1-fc_therap4clr.jpg GRAPHIC 1512885
8 GRAPHIC tm2022154d1-fc_pkce4clr.jpg GRAPHIC 1993697
9 GRAPHIC tm2022154d1-fc_bryost4clr.jpg GRAPHIC 2984737
10 GRAPHIC tm2022154d1-fc_dhabwlr.jpg GRAPHIC 586822
11 GRAPHIC tm2022154d1-bc_coverage4clr.jpg GRAPHIC 1175491
12 GRAPHIC tm2022154d1-lc_overall4clr.jpg GRAPHIC 2532718
13 GRAPHIC lg_gemini-4clr.jpg GRAPHIC 158276
14 GRAPHIC tm2023267d15-pc1.jpg GRAPHIC 640274
15 GRAPHIC tm2023267d15-pc2.jpg GRAPHIC 559015
  Complete submission text file 0001104659-20-120571.txt   26904955
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-38045 | Film No.: 201281142
SIC: 2834 Pharmaceutical Preparations